// App-Quantinova.ai

PB1366 : Safety and Efficacy of Apixaban as Thromboprophylaxis in Multiple Myeloma Patients Receiving Chemotherapy: a Prospective Cohort Study

Researchers

Presenter

  • Z. Sayar

Principal Investigators

  • C. Gates

  • S. Bristogiannis

  • A. Patel

  • K. Yong

  • M. Thomas

Medical Centers

  • University College London Hospitals NHS Foundation Trust, London, UK; Whittington Hospital, London, UK, London, England, United Kingdom

  • Evangelismos Hospital, Athens, Greece

  • Kings College London, London, United Kingdom

  • University College Hospitals London NHS Foundation Trust, London, England, United Kingdom

Locations

  • United Kingdom

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Multiple Myeloma

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved